Replication cycle of SARS-CoV-2 in 3D

Study reveals the SARS-CoV-2 replication cycle in 3D in human lung cells Understanding how SARS-CoV-2 hijacks host cell machineries will help in developing therapeutic strategies, including drugs Researchers relied on the imaging facilities at EMBL Heidelberg and state-of-the art imaging techniques Results published in Cell Host & Microbe As the global coronavirus pandemic continues, scientists are […]

continue reading

SLS group acquires leading US supplier for radiopharmaceutical logistics, Associated Couriers Inc.

Associated Couriers Inc. (AC), a courier and delivery service provider originally specialized in the radiopharmaceutical sector, was founded in St. Louis (MO) in 1997 and since then successfully developed into a market leader in life science related logistics services. AC actually owns a distribution network covering large parts of the USA (38 states), operates with […]

continue reading

ANDRITZ to supply China’s largest melting furnaces to Weiqiao Aluminum Group

International technology group ANDRITZ has received an order from Zouping Hongfa Aluminium Science Technology Co., Ltd., part of Weiqiao Aluminum Group, to supply one melting and holding furnace cell for its plant in Shandong Province, China. Start-up is scheduled for the first quarter of 2022. The new furnace cell supplied by ANDRITZ will incorporate the […]

continue reading

Quick Specialized Healthcare Logistics Sponsors World Cord Blood Day 2020 Featuring Top Transplant Doctors and Researchers

Quick Specialized Healthcare Logistics is the official sponsor of World Cord Blood Day 2020, which takes place on November 17, 2020. The virtual conference will provide important information about cord blood’s potential in stem cell transplants, regenerative medicine, and CAR-NK cell therapy, as well as the potential use of cord tissue for COVID-19 related MIS-C. […]

continue reading

Immunologisches Gedächtnis nach ausgeheilter Sars-CoV-2-Infektion

Bisher war unklar, ob eine überstandeneSARS-CoV-2-Infektion beziehungsweise eine COVID-19-Erkrankung zu einem anhaltenden immunologischen Gedächtnis führt und dies somit vor einer erneuten Infektion schützen kann. So hatten mehrere Studien gezeigt, dass SARS-CoV-2-spezifische Antikörper bei vielen Menschen mit überstandener COVID-19-Erkrankung nur über wenige Monate nachweisbar sind und daher möglicherweise auch nur einen zeitlich begrenzten Schutz vor einer […]

continue reading

Brain Implant Gives New Hope to Epileptics

The British CANDO project develops brain implants for epileptics which could actively avoid life-threatening seizures. Measuring only a few micrometers, the implants are assembled with a FINEPLACER® high-precision die bonder. In the brain, nerve cells generate rhythmic activity or ‘brain waves’. In many neurological diseases, these rhythms are disrupted, producing abnormal patterns of activity. In epilepsy, […]

continue reading

Scientists identify synthetic mini-antibody to combat COVID-19

Llama mini-antibodies and their synthetic imitations The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus to hook onto the cell surface, the spike protein binds ACE2 using three finger-like protrusions, called the receptor binding domains (RBDs). Blocking the […]

continue reading

Immunic, Inc. Announces 200 Patients Enrolled in Its Phase 2 CALVID-1 Trial of IMU-838 for the Treatment of Moderate COVID-19, Allowing for Main Phase 2 Efficacy Analysis to Proceed

Immunic, Inc. (Nasdaq: IMUX),a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced that the company has enrolled and randomized 200 patients, pre-specified in the protocol as sufficient to perform the main efficacy analysis of the phase 2 part of the CALVID-1 trial for […]

continue reading